14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IOVA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Iovance Biotherapeutics, Inc. stock price on Wednesday moving 10.62% between high and low
(Updated on May 01, 2024)

Sell candidate since Apr 09, 2024 Loss -5.45% PDF

The Iovance Biotherapeutics, Inc. stock price gained 6.11% on the last trading day (Wednesday, 1st May 2024), rising from $11.78 to $12.50. During the last trading day the stock fluctuated 10.62% from a day low at $11.75 to a day high of $13.00. The price has been going up and down for this period, and there has been a 5.93% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 6 million shares were bought and sold for approximately $71.94 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.32% during the next 3 months and, with a 90% probability hold a price between $9.29 and $19.11 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IOVA Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Iovance Biotherapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $13.15. On a fall, the stock will find some support from the short-term average at $11.87. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -28.45%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Iovance Biotherapeutics, Inc. stock

Iovance Biotherapeutics, Inc. finds support from accumulated volume at $12.03 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.25 between high and low, or 10.62%. For the last week, the stock has had daily average volatility of 5.83%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IOVA) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Iovance Biotherapeutics, Inc. to open at $12.42, and during the day (based on 14 day Average True Range), to move between $11.74 and $13.26, which gives a possible trading interval of +/-$0.761 (+/-6.08%) up or down from last closing price. If Iovance Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 12.17% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $12.03 (3.76%) than the resistance at $13.91 (11.28%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Iovance Biotherapeutics, Inc. stock A Buy?

Iovance Biotherapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.260 Sell Candidate Unchanged

Predicted Opening Price for Iovance Biotherapeutics, Inc. of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$12.42 ( 0.674%) $12.50

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IOVA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 13.66 9.31 %
R2 13.19 5.49 %
R1 12.89 3.14 %
Current price: 12.50
Support S1 11.94 -4.49 %
S2 11.64 -6.84 %
S3 11.17 -10.65 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 15.36 22.88 %
R2 15.10 20.80 %
R1 13.91 11.28 %
Current price 12.50
Support S1 12.03 -3.76%
S2 11.89 -4.88%
S3 9.95 -20.40%

FAQ

What is the symbol for Iovance Biotherapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Iovance Biotherapeutics, Inc. is IOVA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Iovance Biotherapeutics, Inc. Stock?
Iovance Biotherapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Iovance Biotherapeutics, Inc. Stock?
Iovance Biotherapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Iovance Biotherapeutics, Inc. Stock.

What's the current price of Iovance Biotherapeutics, Inc. Stock?
As of the end of day on the May 01, 2024, the price of an Iovance Biotherapeutics, Inc. (IOVA) share was $12.50.

What is the 52-week high and low for Iovance Biotherapeutics, Inc. Stock?
The 52-week high for Iovance Biotherapeutics, Inc. Stock is $18.33 and the 52-week low is $3.21.

What is the market capitalization of Iovance Biotherapeutics, Inc. Stock?
As of the May 01, 2024, the market capitalization of Iovance Biotherapeutics, Inc. is 3.491B.

When is the next earnings date for Iovance Biotherapeutics, Inc.?
The upcoming earnings date for Iovance Biotherapeutics, Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers... IOVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT